Older adults with HIV are at significantly higher risk for cutaneous malignancies when compared with younger patients with HIV.

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...

Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs) or venereal diseases, are infections spread primarily through ...

Why is AIDS a syndrome and not a disease? What is syndrome?Lookman (by SMS) AIDS is the result of untreated HIV (Human Immunodeficiency Virus). Over time, HIV destroys CD4-T white blood cells, ...

One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential ...

More than half of the people living with HIV in Philadelphia are 50 and older, and they face greater risk of frailty and impairment.